Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
Bulios Fair Price
$6.85
47.0% upside
Trenutna cena
$4.66
Po podatkih Bulios Fair Price je delnica ORMP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Oramed Pharmaceuticals Inc. is an Israeli biotechnology company specializing in the development of oral drugs for patients with diabetes. The company focuses on the research and development of oral insulin and other peptide-based drugs that aim to replace the need for injectable administration. Oramed Pharmaceuticals seeks to provide more convenient and effective treatment options for patients with diabetes. Shares of Oramed Pharmaceuticals Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following innovations in diabetes treatment.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Nadav Kidron
Employees
13
Headquarters
New York City
Prihajajoči dogodki
Earnings
Upcoming earnings report